| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HOX transcript antisense RNA | 0.475 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
SOD2 overlapping transcript 1 | 0.722 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
kinesin family member 28, pseudogene | 0.839 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
BCL2 like 11 | 0.510 | 0.731 | 0.89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Inflammatory bowel disease-20 | 0.890 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
insulin like 5 | 0.792 | 0.231 | 0.14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
H3 clustered histone 9, pseudogene | 0.656 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | |||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
cadherin 5 | 0.561 | 0.692 | 0.51 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
TMED7-TICAM2 readthrough | 0.438 | 0.769 | 2.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
aortic aneurysm, familial abdominal 1 | 0.695 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
poly(ADP-ribose) polymerase 2 | 0.663 | 0.538 | 2.3E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
microRNA 466 | 0.722 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
mastermind like domain containing 1 | 0.650 | 0.500 | 0.63 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ARAP1 antisense RNA 2 | 0.931 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
VIM antisense RNA 1 | 0.780 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
gap junction protein gamma 1 | 0.722 | 0.385 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
RBM14-RBM4 readthrough | 0.647 | 0.615 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
ATP binding cassette subfamily C member 5 | 0.606 | 0.654 | 4.2E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
nuclear receptor subfamily 1 group H member 3 | 0.566 | 0.692 | 0.90 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
protein tyrosine phosphatase receptor type U | 0.581 | 0.654 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
ARAP1 antisense RNA 1 | 0.839 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |